-- Zhangzhou Pientzehuang Pharmaceutical's (SHA:600436) attributable profit fell 27% to 2.16 billion yuan in 2025 from 2.98 billion yuan in 2024, according to a Thursday filing with the Shanghai bourse.
Earnings per share at the drug company decreased to 3.58 yuan from 4.93 yuan in the previous year.
Operating revenue declined 17% year over year to 9 billion yuan from 10.8 billion yuan.